Company intelligence / Profile preview
Zhejiang Wecome Pharmaceutical Company Limited
- Ownership
- Private
- Employees
- ~1100
- Development stage
- Commercial
Overview
Zhejiang Wecome Pharmaceutical is a commercial-stage pharmaceutical manufacturer specializing in both modern traditional Chinese medicines and select Western medicines. Its portfolio includes proprietary herbal formulations as well as generic pharmaceuticals like roxithromycin soft capsules. The company is active primarily within the domestic Chinese market.
- Therapeutic areas
- GastroenterologyWomen's HealthInfectious Diseases
- Modalities
- Small molecules (modern Chinese medicine and Western medicine, including capsules, tablets, granules, soft capsules, pills)Traditional Chinese Medicine formulations
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Zhejiang Wecome Pharmaceutical Company Limited.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zhejiang Wecome Pharmaceutical Company Limited.